Skip to content

Impact of mindfulness-based cognitive therapy (MBCT) on anxiety, depression, and subjective happiness in Russian first-year psychology students

Anton Skolzkov

DOI: 10.31124/advance.12319667 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Non-randomized controlled trial Pilot study
Sample size 83
Population First-year psychology students at Ural Federal University named after B.N. Yeltsin
Intervention Mindfulness-based cognitive therapy (MBCT)
Topics Anxiety Depression Meditation
Key findings MBCT reduced depression and increased subjective happiness among first-year psychology students.

Abstract

Globally, there has been an increase in the number of people with anxiety disorders and depression which is confirmed by particular Russian data. Despite overall improvements in the global economic situation in recent decades, general stress levels have not decreased. University freshmen are particularly vulnerable to stress. Therefore, this pilot study assesses the effectiveness of mindfulness training aimed at maintaining Russian students’ mental and physical health. The participants were 83 freshmen from the Psychology Department of Ural Federal University named after B.N. Yeltsin. Data collection was completed in November 2019. A non-randomized controlled trial was conducted using a mindfulness-based cognitive therapy (MBCT) program. Results show that MBCT reduced depression and increased subjective happiness among first-year psychology students. Frequent mindfulness meditation practice and studying theoretical materials is associated with higher rates of positive results. The findings suggest that MBCT can be effective in working with first-year students in the Psychology Department of Ural Federal University. Nevertheless, further research is required before implementing the program on a broad scale in Russian universities.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Explore topics